Autosomal dominant polycystic kidney disease

Nefrologia

Volumn 23, Issue SUPPL.1, 2003, Pages 14-22

  Torres, V E ^a   Harris, P C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYCYSTIC KIDNEY DISEASE 1 PROTEIN; POLYCYSTIN; PROTEIN;

GENETIC LINKAGE; GENETICS; HUMAN; KIDNEY POLYCYSTIC DISEASE; NUCLEOTIDE SEQUENCE; PATHOLOGY; REVIEW;

DNA MUTATIONAL ANALYSIS; HUMANS; LINKAGE (GENETICS); POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PROTEINS; TRPP CATION CHANNELS;

EID: 0038317844     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Gabow P: Autosomal dominant polycystic kidney disease. N Engl J Med 329: 323-342, 1993.
2. Dalgaard OZ: Bilateral polycystic disease of the kidneys: a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand 328 (Supl.): 1-255, 1957.
3. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT: Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota. Am J Kid Dis 2: 630-639, 1983.
4. Cooper L: USRDS, 2001 Annual Data Report. Nephrol News Issues 15: 34-38, 2001.
5. European Polycystic Kidney Disease Consortium: The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell 77: 881-894, 1994.
6. International Polycystic Kidney Disease Consortium: The complete structure of the PKD1 gene and its protein. Cell 81: 289-298, 1995.
7. Hughes J, Ward CJ, Peral B, et al.: The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nature Genet 10: 151-160, 1995.
8. Mochizuki T, Wu G, Hayashi T, et al.: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339-1342, 1996.
9. Daoust MC, Reynolds DM, Bichet DG, Somlo S: Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. Genomics 25: 733-736, 1995.
10. de Almeida S, de Almeida E, Peters D, et al.: Autosomal dominant polycystic kidney disease: evidence for the existence of a third locus in a Portuguese family. Hum Genet 96: 83-88, 1995.
11. De Almeida E, Prata MM, De Almeida S, Lavinha J: Longterm follow-up of a family with autosomal dominant polycystic kidney disease type 3. Nephrol Dial Transplant 14: 631-634, 1999.
12. Pei Y, Paterson AD, Wang KR, et al.: Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease. Am J Hum Genet 68: 355-363, 2001.
13. Torra R, Badenas C, Darnell A, et al.: Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. J Am Soc Nephrol 7: 2142-2151, 1996.
14. Van Dijk MC, PC. Peters, DJ. Breuning, MH: Intracranial aneurysms in polycystic kidney disease linked to chromosome 4. J Am Soc Neph 6 (6): 1670-1673, 1995.
15. Hateboer N, Van Dijk M, Bogdanova N, et al.: Comparison of phenotypes of polycystic kidney disease types 1 and 2. Lancet 353: 103, 1999.
16. Sandford R, Sgotto B, Aparacio S, et al.: Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains. Hum Mol Genet 6 (9): 1483-1489, 1997.
17. Bycroft M, Bateman A, Clarke J y cols.: The structure of a PKD domain from polycystin-1: implication for polycystic kidney disease. EMBO Journal 18: 297-305, 1999.
18. Moy GW, Mendoza LM, Schulz JR, Swanson WJ, Glabe CG, Vacquier VD: The sea urchin sperm receptor for egg jelly is a modular protein with extensive homology to the human polycystic kidney disease protein, PKD1. J Cell Biol 133 (4): 809-817, 1996.
19. Mengerink KJ, Moy GW, Vacquier VD: suREJ3, a polycystin-1 protein, is cleaved at the GPS domain and localizes to the acrosomal region of sea urchin sperm. J Biol Chem 277 (2): 943-948, 2002.
20. Huan Y, Van Adelsberg J: Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Invest 104 (10): 1459-1468, 1999.
21. Wilson P, Geng L, Li X, Burrow C: The PKD1 gene product, «Polycystin-1», is a tyrosine-phosphorylated protein that colocalizes with alpha 2 beta 1-integrin in focal clusters in adherent renal epithelia. Lab Invest 79 (10): 1311-1323, 1999.
22. Ibraghimov-Beskrovnaya O, Bukanov NO, Donohue LC, Dackowski WR, Klinger KW, Landes GM: Strong homophilic interactions of the Ig-like domains of polycystin-1,the protein product of an autosomal dominant polycystic kidney disease gene, PKD1. Hum Mol Genet 9 (11): 1641-1649, 2000.
23. Scheffers MS, Van der Bent P, Prins F, et al.: Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells. Hum Mol Genet 9 (18): 2743-2750, 2000.
24. Xu GM, Sikaneta T, Sullivan BM, et al.: Polycystin-1 interacts with intermediate filaments. J Biol Chem 276 (49): 46544-46552, 2001.
25. Qian F, Germino FJ, Cai Y, Zhang X, Somlo S, Germino GG: PKD1 interacts with PKD2 through a probable coiled-coil domain. Nature Genet 16: 179-183, 1997.
26. Tsiokas L, Kim E, Arnould T, Sukhatme VP, Walz G: Homo-and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc Natl Acad Sci, USA 94: 6965-6970, 1997.
27. Parnell SC, Magenheimer BS, Maser RL, et al.: The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem Biophys Res Commun 251: 625-631, 1998.
28. DeAngelis CD, Rosenberg RN, Smith JM: Genomic medicine and the individual patient -Byte to bedside- A call for papers. J Am Med Assoc 284 (20): 22, 2000.
29. Somlo S, Ehrlich B: Human disease: Calcium signaling in polycystic kidney disease. Curr Biol 11: R356-R360, 2001.
30. Hanaoka K, Devuyst O, Schwiebert E, Wilson P, Guggino W: A role for CFTR in human autosomal dominant polycystic kidney disease. Am J Physiol 270: C389-C399, 1996.
31. 2+-permeable non-selective cation channel. Proc Natl Acad Sci USA 98: 1182-1187, 2001.
32. 2+ homeostasis in polycystic kidney disease. Biochem Biophys Res Commun 282 (1): 341-350, 2001.
33. Stayner C, Zhou J: Polycystin channels and kidney disease. Trends Pharmacol Sci 22 (11): 543-546, 2001.
34. Qian F, Watnick TJ, Onuchic LF, Germino GG: The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type 1. Cell 87: 979-987, 1996.
35. Loftus BJ, Kim U-J, Sneddon VP, et al.: Genome duplications and other features in 12 Mbp of DNA sequence from human chromosome 16p and 16q. Genomics 60: 295-308, 1999.
36. Rossetti S, Strmecki L, Gamble V, et al.: Mutation analysis of the entire PKD1 gene: Genetic and diagnostic implications. Am J Hum Genet 68: 46-63, 2001.
37. Rossetti S, Chauveau D, Walker D, et al.: A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int 61 (5): 1588-1599, 2002.
38. Phakdeekitcharoen B, Watnick T, Germino GG: Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples. J Am Soc Nephrol 12: 955-963, 2001.
39. Geberth S, Ritz E, Zeier M, Stier E: Anticipation of age at renal death in autosomal dominant polycystic kidney disease (ADPKD)? Nephrol Dial Transplant 10: 1603-1606, 1995.
40. Milutinovic J, Rust PF, Fialkow PJ, et al.: Intrafamilial phenotypic expression of autosomal dominant polycystic kidney disease. Am J Kidney Dis 19: 465-472, 1992.
41. Boletta A, Qian F, Onuchic LF, et al: Biochemical characterization of bona fide polycystin-1 in vitro and in vivo. Am J Kidney Dis 38 (6): 1421-1429, 2001.
42. Ponting CP, Hofmann K, Bork P: A latrophilin/CL-1-like GPS domain in polycystin-1. Curr Biol 9: R585-R588, 1999.
43. Grantham JJ: Pathogenesis of autosomal dominant polycystic kidney disease: recent developments. Contrib Nephrol 122: 1-9, 1997.
44. Germino G: Autosomal dominant polycystic kidney disease: a two-hit model. Hosp Pract 32: 81-102, 1997.
45. Yamaguchi T, Pelling J, Ramaswamy N, et al.: cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 57 (4): 1460-1471, 2000.
46. Sutters M, Yamaguchi T, Maser R, et al.: Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells. Kid Int 60: 484-494, 2001.
47. Hanaoka K, Guggino W: cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol 11: 1179-1187, 2000.
48. Marfella-Scivittaro C, Quinones A, Orellana SA: cAMP-dependent protein kinase and proliferation differ in normal and polycystic kidney epithelia. Am J Physiol Cell Physiol 282 (4): C693-707, 2002.
49. Sullivan LP, Wallace DP, Grantham JJ: Chloride and fluid secretion in polycystic kidney disease. J Am Soc Nephrol 9 (5): 903-916, 1998.
50. Gregoire J, Torres V, Holley K, Farrow G: Renal epithelial hyperplastic and neoplastic proliferation in autosomal dominant polycystic kidney disease. Am J Kidney Dis 9: 27-38, 1987.
51. Woo D: Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med 333: 18-25, 1995.
52. Sujansky E, Kreutzer SB, Johnson AM, Lezotte DC, Schrier RW, Gabow PA: Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease. Am J Med Genet 35 (4): 510-515, 1990.
53. Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid-Smith P, Danks DM: Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 343: 824-827, 1994.
54. Nicolau C, Torra R, Badenas C, et al.: Autosomal dominant polycystic kidney disease types 1 and 2: assessment of US sensitivity for diagnosis. Radiology 213 (1): 273-276, 1999.
55. Torres VE, Wilson DM, Hattery RR, Segura JW: Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 22: 513-519, 1993.
56. Torres V, Keith D, Offord K, Kon S, Wilson D: Renal ammonia in autosomal dominant polycystic kidney disease. Kidney Int 45 (6): 1745-1753, 1994.
57. Ecder T, Schrier RW: Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects. J Am Soc Neph 12 (1): 194-200, 2001.
58. Chapman AB, Johnson AM, Gabow PA: Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5 (5): 1178-1185, 1994.
59. Segura JW, King BF, Jowsey SG, Martin P, Zincke H: Chronic pain and its medical and surgical management in renal cystic diseases. In: Watson ML, Torres VE, eds. Polycystic Kidney Disease. Oxford: Oxford Medical Publications. p. 462-480, 1996.
60. Klahr S, Breyer J, Beck G, et al.: Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease modification of diet in renal disease study group. J Am Soc Nephrol 5 (12): 2037-2047, 1995.
61. Johnson A, Gabow P: Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. J Am Soc Nephrol 8: 1560-1567, 1997.
62. Torres V: Polycystic liver disease. In: Watson MT, VE., ed. Polycystic Kidney Disease. Oxford: Oxford Medical Publications. p. 500-529, 1996.
63. Sherstha R, McKinley C, Russ P, et al.: Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease. Hepatology 26 (5): 1282-1286, 1997.
64. Torres V, Rastogi S, King B, Stanson A, Gross J, Jr., Nagorney D: Hepatic venous outflow obstruction in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5: 1186-1192, 1994.
65. Telenti A, Torres V, Gross J, Jr, Van Scoy R, Brown M, Hattery R, Jr.: Hepatic cyst infection in autosomal dominant polycystic kidney disease. Mayo Clin Proc 65: 933-942, 1990.
66. Pirson Y, Chauveau D, Torres VE: Management of cerebral aneurysms in autosomal dominant polycystic kidney disease: unruptured asymptomatic intracranial aneurysms. J Am Soc Nephrol 13: 269-276, 2002.
67. Griffin MD, Torres VE, Grande JP, Kumar R: Vascular expression of polycystin. J Am Soc Nephrol 8: 616-626, 1997.
68. Torres VE, Cai Y, Chen X, et al.: Vascular expression of polycystin 2. J Am Soc Nephrol 12: 1-9, 2001.
69. International Polycystic Kidney Disease Consortium: Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. Cell 81: 289-298, 1995.
70. Inagawa T. Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan,between 1980-1989 and 1990-1998. Stroke 32 (7): 1499-1507, 2001.
71. Elzinga LW, Bennett WM: Miscellaneous renal and systemic complications of autosomal dominant polycystic kidney disease including infection. In: Watson ML, Torres VE, eds. Polycystic Kidney Disease. Oxford: Oxford Medical Publications. p. 483-499, 1996.
72. Ubara Y, Katori H, Tagami T, et al.: Transcatheter renal arterial embolization therapy on a patient with polycystic kidney disease on hemodialysis. Am J Kidney Dis 34 (5): 926-931, 1999.
73. Dunn MD, Portis AJ, Elbahnasy AM, et al.: Laparoscopic nephrectomy in patients with end-stage renal disease and autosomal dominant polycystic kidney disease (see comments). Am J Kidney Dis 35 (4): 720-725, 2000.
74. Qian Q, Harris PC, Torres VE: Treatment prospects for autosomal dominant polycystic kidney disease. Kid Int 59: 2005-2022, 2001.
75. Que F, Nagorney D, Gross J, Jr, Torres V: Liver resection and cyst fenestration in the treatment of severe polycystic liver disease. Gastroenterology 108: 487-494, 1995.